Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
Bosanquet
Nick
N
Yeates
Andrew
A
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D018803:Models, Economic; D019057:Quality-Adjusted Life Years; D006113:United Kingdom
D002800:Cholinesterase Inhibitors